Martell Bridget A 4
4 · Aligos Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Martell Bridget A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-25+5,860→ 5,860 totalExercise: $7.63Exp: 2035-06-25→ Common Stock (5,860 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2026 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.